Cholinesterase inhibitors and atypical antipsychotics may help manage dementia and psychosis in Parkinson's disease

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.3, 2007-03, pp. : 7-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Atypical Antipsychotics in the Treatment of Psychosis and Agitation Associated with Dementia

By Madhusoodanan S.

CNS Drugs, Vol. 12, Iss. 2, 1999-08 ,pp. : 135-150

Adis International

Access to resources Recommend Favorite

Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?

By Liberini P. Valerio A. Memo M. Spano P.

Trends in Pharmacological Sciences, Vol. 17, Iss. 4, 1996-04 ,pp. : 155-160

Elsevier

Access to resources Recommend Favorite

Atypical antipsychotics are an option for treating serious psychosis of Alzheimer's disease, despite safety concerns and lack of evidence

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 11, 2007-11 ,pp. : 13-15

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for Alzheimer's Disease

By Grutzendler J. Morris J.C.

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 41-52

Adis International

Access to resources Recommend Favorite

Alternatives to Atypical Antipsychotics for the Management of Dementia-Related Agitation

By Passmore Michael J.

Drugs & Aging, Vol. 25, Iss. 5, 2008-01 ,pp. : 381-398

Adis International

Access to resources Recommend Favorite